Professor Usha Menon

Dikutip oleh

	Semua	Sejak 2020
Kutipan	40802	19606
indeks-h	90	63
indeks-i10	341	258

4200

2100

1050

3150

20032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025124 163 234 310 385 386 496 685 861 1105 1400 1558 1858 2379 2586 2833 3074 3742 3781 4123 3416 3758 748

Akses publik

Lihat semua

331 artikel

7 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Ian JacobsPresident & Vice Chancellor, University of New South Wales, Sydney, AustraliaEmail yang diverifikasi di unsw.edu.au
Ranjit ManchandaProfessor of Gynaecological Oncology and Consultant Gynaecological OncologistEmail yang diverifikasi di qmul.ac.uk
Steven SkatesMassachusetts General HospitalEmail yang diverifikasi di mgh.harvard.edu
John F. TimmsUniversity College LondonEmail yang diverifikasi di ucl.ac.uk
Susan RamusUniversity of New South WalesEmail yang diverifikasi di unsw.edu.au
alexey zaikinProfessor, University College LondonEmail yang diverifikasi di ucl.ac.uk
Anne LanceleyProfessor of Women's Cancer CareEmail yang diverifikasi di ucl.ac.uk
a.mcguireProfessor of Health Economics, London School of EconomicsEmail yang diverifikasi di lse.ac.uk
Saskia SandersonData Science Lead, UK Mental Health Mission, and Senior Research Fellow, King's College LondonEmail yang diverifikasi di kcl.ac.uk
Robert BastMD Anderson Cancer CenterEmail yang diverifikasi di mdanderson.org
Evans DG*, Evans G*University of ManchesterEmail yang diverifikasi di mft.nhs.uk
Lesley J. FallowfieldDirector SHORE-C, University of SussexEmail yang diverifikasi di sussex.ac.uk
Stephen PereiraUniversity College LondonEmail yang diverifikasi di ucl.ac.uk
Paul PharoahCedars-Sinai Medical CenterEmail yang diverifikasi di cshs.org
Andrew TeschendorffCAS Key Lab of Computational Biology, Shanghai Institute of Nutrition and Health, ShanghaiEmail yang diverifikasi di sinh.ac.cn
Rainer CramerProfessor of Mass Spectrometry and Bioanalytical SciencesEmail yang diverifikasi di reading.ac.uk
Ali TISSDasman Diabetes InstituteEmail yang diverifikasi di dasmaninstitute.org
Alexander GammermanProfessor of Computer Science, Royal Holloway University of LondonEmail yang diverifikasi di rhul.ac.uk
Nazar N Amso PhD, FRCOG, FHEAEmeritus Professor, Cardiff UniversityEmail yang diverifikasi di cardiff.ac.uk
Peter SasieniProfessor of Cancer Prevention, King's College LondonEmail yang diverifikasi di kcl.ac.uk

Ikuti

Professor Usha Menon

MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology, University College

Email yang diverifikasi di ucl.ac.uk - Beranda

Cancer screening diagnosis risk prediction Biomarkers


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Rethinking ovarian cancer: recommendations for improving outcomes S Vaughan, JI Coward, RC Bast, A Berchuck, JS Berek, JD Brenton, ... Nature Reviews Cancer 11 (10), 719-725, 2011	1580	2011
Association analysis identifies 65 new breast cancer risk loci K Michailidou, S Lindström, J Dennis, J Beesley, S Hui, S Kar, A Lemaçon, ... Nature 551 (7678), 92-94, 2017	1516	2017
Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer DD Bowtell, S Böhm, AA Ahmed, PJ Aspuria, RC Bast Jr, V Beral, ... Nature reviews Cancer 15 (11), 668-679, 2015	1289	2015
Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial IJ Jacobs, U Menon, A Ryan, A Gentry-Maharaj, M Burnell, JK Kalsi, ... The Lancet 387 (10022), 945-956, 2016	1257	2016
Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies Collaborative Group on Hormonal Factors in Breast Cancer The lancet oncology 13 (11), 1141-1151, 2012	1253	2012
Association between endometriosis and risk of histological subtypes of ovarian cancer: a pooled analysis of case–control studies CL Pearce, C Templeman, MA Rossing, A Lee, AM Near, PM Webb, ... The lancet oncology 13 (4), 385-394, 2012	1156	2012
Polygenic risk scores for prediction of breast cancer and breast cancer subtypes N Mavaddat, K Michailidou, J Dennis, M Lush, L Fachal, A Lee, JP Tyrer, ... The American Journal of Human Genetics 104 (1), 21-34, 2019	1075	2019
Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK … U Menon, A Gentry-Maharaj, R Hallett, A Ryan, M Burnell, A Sharma, ... The lancet oncology 10 (4), 327-340, 2009	1065	2009
Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer AE Teschendorff, U Menon, A Gentry-Maharaj, SJ Ramus, ... Genome research 20 (4), 440-446, 2010	974	2010
Management of women who test positive for high-risk types of human papillomavirus: the HART study J Cuzick, A Szarewski, H Cubie, G Hulman, H Kitchener, D Luesley, ... The Lancet 362 (9399), 1871-1876, 2003	771	2003
Screening for ovarian cancer: a pilot randomised controlled trial IJ Jacobs, SJ Skates, N MacDonald, U Menon, AN Rosenthal, AP Davies, ... The Lancet 353 (9160), 1207-1210, 1999	737	1999
Progress and challenges in screening for early detection of ovarian cancer IJ Jacobs, U Menon Molecular & Cellular Proteomics 3 (4), 355-366, 2004	694	2004
New tumor markers: CA125 and beyond RC Bast Jr, D Badgwell, Z Lu, R Marquez, D Rosen, J Liu, KA Baggerly, ... International journal of gynecological cancer 15, 274-281, 2005	686	2005
Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer SE Bojesen, KA Pooley, SE Johnatty, J Beesley, K Michailidou, JP Tyrer, ... Nature genetics 45 (4), 371-384, 2013	662	2013
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial U Menon, A Gentry-Maharaj, M Burnell, N Singh, A Ryan, C Karpinskyj, ... The Lancet 397 (10290), 2182-2193, 2021	585	2021
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian Cancer SJ Ramus, H Song, E Dicks, JP Tyrer, AN Rosenthal, MP Intermaggio, ... Journal of the National Cancer Institute 107 (11), djv214, 2015	533	2015
Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study W Sieh, M Köbel, TA Longacre, DD Bowtell, A DeFazio, MT Goodman, ... The lancet oncology 14 (9), 853-862, 2013	492	2013
Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer CM Phelan, KB Kuchenbaecker, JP Tyrer, SP Kar, K Lawrenson, ... Nature genetics 49 (5), 680-691, 2017	467	2017
GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer PDP Pharoah, YY Tsai, SJ Ramus, CM Phelan, EL Goode, K Lawrenson, ... Nature genetics 45 (4), 362-370, 2013	428	2013
Contribution of Germline Mutations in the RAD51B, RAD51C, and RAD51D Genes to Ovarian Cancer in the Population H Song, E Dicks, SJ Ramus, JP Tyrer, MP Intermaggio, J Hayward, ... Journal of Clinical Oncology 33 (26), 2901-2907, 2015	415	2015

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–20

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama